Actavis buying Warner Chilcott in $8.5B deal
Monday, May 20, 2013 - 08:30
in Mathematics & Economics
Actavis is buying Warner Chilcott in an all-stock transaction valued at about $8.5 billion which would create the third-biggest specialty pharmaceutical company in the U.S.